Most Read Articles
Pearl Toh, 2 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
5 days ago
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.

High protein intake helps defer frailty in elderly adults

25 Dec 2019

Frailty in very old adults with high protein intake appears to be delayed—an effect that is partly mediated by energy intake, a study reports.

The study used data from the Newcastle 85+ study and included 668 community-dwelling older adults (59 percent female) with complete dietary assessment and Fried frailty status (FFS; baseline and at 1.5, 3 and 5 years of follow-up).

Researchers estimated dietary intake using two-by-24-hour multiple pass recalls at baseline. FFS was based on the following criteria: shrinking, physical endurance/energy, low physical activity, weakness and slow walking speed.

In multistate models, the likelihood of transitioning from prefrail to frail decreased with every one-unit increase in protein intake (g/kg aBW/d; hazard ratio [HR], 0.44, 95 percent confidence interval [CI], 0.25–0.77) but not for the other transitions.

Frailty also occurred less frequently in individuals with protein intakes of ≥0.8 g/kg aBW/d (HR, 0.60, 95 percent CI, 0.43–0.84) and ≥1 g/kg aBW/d (HR, 0.63, 95 percent CI, 0.44–0.90) from 85–90 years of age. When controlled for energy intake, the association was mitigated, although the direction remained the same (eg, g/kg aBW/d model: HR, 0.71, 95 percent CI, 0.36–1.41).

The present data suggest that “protein modulates frailty transitions not only because it provides energy but also for its functional and structural role,” the researchers said. Prevention strategies in very old adults should therefore include provision of protein and energy.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 2 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
5 days ago
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.